全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Fatal Blastoid Variant Mantle Cell Lymphoma in a Patient with Sj?gren's Syndrome

DOI: 10.1155/2013/831708

Full-Text   Cite this paper   Add to My Lib

Abstract:

Primary Sj?gren's syndrome (pSS) is an autoimmune disorder of the exocrine glands presenting with progressive ocular and oral dryness, parotid gland enlargement, and often with extraglandular manifestations. In this group of patients the risk of development of non-Hodgkin's lymphoma is 16-fold compared to healthy population, mainly of the MALT lymphoma type. This case reports a 52-year-old woman with pSS developing a progressively growing mass at face and neck compatible with blastoid variant mantle cell lymphoma and a fatal outcome. 1. Introduction Primary Sj?gren's syndrome (pSS) is an autoimmune disease characterized by lymphocytic infiltration of exocrine glands together with polyclonal B-cell activation [1]. Patients have an increased risk of up to 6% per year for developing non-Hodgkin's (NHL) B-cell lymphomas, including mucosa-associated lymphoid tissue (MALT) lymphomas in 70% of cases, preferentially extranodal marginal zone (MZ), located mainly in the major salivary glands [2]. This complication is associated with excess in the overall mortality rate in pSS patients. The association between pSS and lymphoma has been recognized since 1964 [3]; thus, attention is drawn to regular control of patients with this disease. Several clinical and serological markers have been reported to predict the development of NHL in pSS in different series. Among these parameters, patients with pSS and splenomegaly, persistent enlargement of parotid glands, lymphadenopathy, palpable purpura, cryoglobulinemia, low levels of C4, neutropenia, or lymphocytopenia have more than 5-fold increased risk of NHL compared to patients without risk factors. This case reports a 52-year-old woman with pSS developing a progressively growing mass at face and neck compatible with blastoid variant mantle cell lymphoma and a fatal outcome. 2. Case Report A 52-year-old woman with a previous history of eight years of pSS (sicca syndrome, positive antinuclear antibodies, rheumatoid factor, and anti-Ro) was admitted to our hospital with the presence of a progressively growing mass on face and neck leading to swallowing and breathing difficulty. She reported chronic inflammatory arthralgias, xerostomia, and xerophthalmia. At physical examination on admission xerostomia and bilateral increase in size of parotid with dysphagia were observed (Figure 1). Cardiopulmonary, neurological, and osteoarticular systems were normal. On the biological analysis, low C4 and low C3 (65?mg/dL) levels were evidenced. High lactic dehydrogenase 777?U/L was also documented. Total leukocyte count was normal

References

[1]  M. Voulgarelis and H. M. Moutsopoulos, “Malignant lymphoma in primary Sj?gren's syndrome,” Israel Medical Association Journal, vol. 3, no. 10, pp. 761–766, 2001.
[2]  N. W. Law and M. Leader, “Bilateral submandibular gland lymphoma in Sj?gren's syndrome,” Postgraduate Medical Journal, vol. 63, no. 736, pp. 135–136, 1987.
[3]  N. Talal and J. J. Bunim, “The development of malignant lymphoma in the course of Sj?gren's syndrome,” The American Journal of Medicine, vol. 36, no. 4, pp. 529–540, 1964.
[4]  M. Voulgarelis, U. G. Dafni, D. A. Isenberg, and H. M. Moutsopoulos, “Malignant lymphoma in primary Sj?gren's syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sj?gren's syndrome,” Arthritis and Rheumatism, vol. 42, no. 8, pp. 1765–1772, 1999.
[5]  G. J. Tobón, Y. Renaudineau, S. Hillion et al., “The Fms-like tyrosine kinase 3 Ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sj?gren's syndrome,” Arthritis and Rheumatism, vol. 62, no. 11, pp. 3447–3456, 2010.
[6]  A. J. M. Balm, P. Delaere, F. J. M. Hilgers, R. Somers, and P. van Heerde, “Primary lymphoma of mucosa associated lymphoid tissue (MALT) in the parotid gland,” Clinical Otolaryngology and Allied Sciences, vol. 18, no. 6, pp. 528–532, 1993.
[7]  G. A. Hyman and M. Wolff, “Malignant lymphomas of the salivary glands. Review of the literature and report of 33 new cases, including 4 cases associated with the lymphoepithelial lesion,” The American Journal of Clinical Pathology, vol. 65, no. 4, pp. 421–438, 1976.
[8]  M. A. Schusterman, M. S. Granick, E. R. Erickson, E. D. Newton, D. C. Hanna, and R. W. Bragdon, “Lymphoma presenting as a salivary gland mass,” Head and Neck Surgery, vol. 10, no. 6, pp. 411–415, 1988.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133